NewAmsterdam Pharma Company N.V. - Ordinary Shares (NQ:NAMS)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
53.3% below 52-week high
19.71
19.1352W Low
42.2052W High
1 Week
11.6% below 1-week high
19.131W Low
22.291W High
NewAmsterdam Pharma Company N.V. - Ordinary Shares (NAMS) traded between $19.13 and $42.20 over the past 52 weeks and last traded at $19.71, 53.3% below its 52-week high. Over the past week it ranged between $19.13 and $22.29.
Past 12 Months
1W
-$0.76
1M
-$2.97
3M
-$9.93
6M
-$10.01
YTD
-$15.49
1Y
-$16.57
NAMS was -45.7% over the past year, -33.7% over six months, -44.0% year to date, -3.7% in the last week.
12 Months vs Market
NAMS
DIA
SPY
QQQ
IWM
Over the past 12 months NAMS returned -45.7% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
1.62× 3-mo avg
Today 2,311,263
3-mo avg 1.4M
1W
1M
3M
6M
YTD
1Y
NAMS most recently traded 2,311,263 shares against a 3-month average daily volume of 1.4M. More NewsRead MoreFrequently Asked QuestionsIs NewAmsterdam Pharma Company N.V. - Ordinary Shares publicly traded?
Yes, NewAmsterdam Pharma Company N.V. - Ordinary Shares is publicly traded.
What exchange does NewAmsterdam Pharma Company N.V. - Ordinary Shares trade on?
NewAmsterdam Pharma Company N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NewAmsterdam Pharma Company N.V. - Ordinary Shares?
The ticker symbol for NewAmsterdam Pharma Company N.V. - Ordinary Shares is NAMS on the Nasdaq Stock Market
What is the current price of NewAmsterdam Pharma Company N.V. - Ordinary Shares?
The current price of NewAmsterdam Pharma Company N.V. - Ordinary Shares is 19.71
When was NewAmsterdam Pharma Company N.V. - Ordinary Shares last traded?
The last trade of NewAmsterdam Pharma Company N.V. - Ordinary Shares was at 10/23/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|